Opioid-Induced Constipation Market Report

Global and Regional Opioid-Induced Constipation Market Details Research Report 2021-2026

  • POSTDATE：Jun 04, 2021
  • PAGES：221
  • REPORT CODE：GMM695969
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • Although opioids are very effective for treating and managing pain, their use frequently results in opioid-induced constipation (OIC). Treatment options for OIC may be as simple as changing diet or as complicated as requiring several medicines and laxatives.

    The Global Opioid-Induced Constipation Market Report provides evaluation of the market development from historical studies. This report further provides forecasts by performing comprehensive market analysis.  It covers thorough market analysis for the forecasted period 2021-2026. Moreover, this market study focuses on market classification into different segments along with thorough analysis of the competitors, key players and their profiles. The market size is calculated on the basis of revenue generated and volume.  Knowing dynamics of the market plays an important role and this report sheds light on dynamics like drivers and restraints.

    Such comprehensive Opioid-Induced Constipation market report further covers factors that influence market along with potent developing factors for various End-users, Types and Regions to outline the most capturing development trends of the Hydraulic Work Supports Industry. In addition, it focuses on some prominent investment sectors in regions such as Latin America, Europe, Asia Pacific, Africa and Middle East. This unique market report presents precious opinion of strategic adjustments for new key entrant as well present groups. In this research analysis, market capacity and consumption potential of prominent players are mentioned.

    In 2020, COVID-19 has had a certain impact on the global economy, so the report considers the impact of COVID-19 on the Global Opioid-Induced Constipation market.

    By Player:

    • AstraZeneca

    • Salix (Bausch Health)

    • Progenics Pharmaceuticals

    • Bayer

    • GSK

    • Sanofi

    • Daiichi Sankyo

    • Takeda Pharmaceuticals

    • Purdue Pharm

    • Nektar Therapeutics

    • Shionogi

    • Prestige

    • Mallinckrodt

    By Type:

    • Methylnaltrexone Bromide

    • Lubiprostone

    • Naloxegol

    • Others

    By End-User:

    • Hospital

    • Pharmacy

    By Geography:

    North America

    • United States

    • Canada

    • Mexico

    Europe

    • Germany

    • United Kingdom

    • France

    • Italy

    • Russia

    • Spain

    • Netherlands

    • Switzerland

    • Turkey

    • Poland

    • Sweden

    • Belgium

    • Austria

    • Others

    Asia

    • China

    • Japan

    • India

    • South Korea

    • Indonesia

    • Thailand

    • Malaysia

    • Singapore

    • Philippines

    • Vietnam

    • Others

    South America

    • Brazil

    • Argentina

    • Colombia

    • Chile

    • Others

    Middle East

    • United Arab Emirates (UAE)

    • Saudi Arabia

    • Others

    Africa

    • Nigeria

    • Egypt

    • South Africa

    • Others

    Oceania

    • Australia

    • New Zealand

    • Others


    Major Reasons to Buy this Report

    This market report is the perfect presentation of the qualitative and quantitative analysis of the market according to categorization considering economic and non-economic factors.

    • It also provides provision of market value (USD Million) data for every segment and sub-segment.

    • This report further focuses on prominent regions and segmentation of the market, which is anticipated to record the rapid growth and dominate the market.

    • Market analysis is done on the basis of major regions covering consumption of the product in particular region and factors affecting the market growth in every region.

    • This market report further sheds light on competitive landscape, which indicates the place of the prominent key players in the market. It also covers a few crucial market strategies followed by the major players of the market such as partnerships, new service launches, business expansions and acquisitions of the companies profiled during last five years.

    • This market study sheds light on a wide range of company profiles, which contain company insights, SWOT analysis for the prominent industry players, company overview and product benchmarking.

    • The present and future market outlook of the industry is also mentioned in this unique market report along with recent development such as drivers, opportunities, challenges and market restricting factors of developed and rising regions.  

    • This market report is the unique depiction of porter’s five forces analysis, which is performed thorough analysis of the market perspectives.  Insights into market scenario is provided through value chain

    •  It further focuses on growth opportunities of upcoming years and depicts market scenario along with market dynamics.

    • This market report also provides six month post-sales analyst support.


    Customization of the Report

    Please feel free to contact our sales team in case of any Query or Customization Requirements. Our expert team will give you right solutions for your query.

  • TABLE OF CONTENT

    1 Opioid-Induced Constipation Market Overview

    • 1.1 Product Definition and Study Scope

      • 1.1.1 Study Scope by Types

      • 1.1.2 Study Scope by Application

    • 1.2 Market Overview and Trends

      • 1.2.1 Global Opioid-Induced Constipation Market Size and Growth Rate from 2016 to 2026

      • 1.2.2 Market Overview (Current Market Status)

      • 1.2.3 Qualitative Analysis of Market Trends

    • 1.3 Business Environment Analysis Tools

      • 1.3.1 PESTEL Analysis

      • 1.3.2 Porter's Five Forces Analysis

      • 1.3.3 Major Deals & Strategic Alliances Analysis

    2 Major Players Market Position

    • 2.1 Global Opioid-Induced Constipation Production Capacity and Market Share by Manufacturers (2016-2021)

    • 2.2 Global Opioid-Induced Constipation Market Revenue and Market Share by Manufacturers (2016-2021)

    • 2.3 Global Opioid-Induced Constipation Market Revenue and Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

    • 2.4 Manufacturers Opioid-Induced Constipation Plant Distribution and Sales Country

    3 Key Competitor and Financial Performance

    • 3.1 AstraZeneca

      • 3.1.1 AstraZeneca - Company Business Overview

      • 3.1.2 AstraZeneca - Company Financial Performance

      • 3.1.3 AstraZeneca - Company Financial Performance of Opioid-Induced Constipation

      • 3.1.4 Opioid-Induced Constipation Product Benchmarking

      • 3.1.5 Strategic Initiatives

    • 3.2 Salix (Bausch Health)

      • 3.2.1 Salix (Bausch Health) - Company Business Overview

      • 3.2.2 Salix (Bausch Health) - Company Financial Performance

      • 3.2.3 Salix (Bausch Health) - Company Financial Performance of Opioid-Induced Constipation

      • 3.2.4 Opioid-Induced Constipation Product Benchmarking

      • 3.2.5 Strategic Initiatives

    • 3.3 Progenics Pharmaceuticals

      • 3.3.1 Progenics Pharmaceuticals - Company Business Overview

      • 3.3.2 Progenics Pharmaceuticals - Company Financial Performance

      • 3.3.3 Progenics Pharmaceuticals - Company Financial Performance of Opioid-Induced Constipation

      • 3.3.4 Opioid-Induced Constipation Product Benchmarking

      • 3.3.5 Strategic Initiatives

    • 3.4 Bayer

      • 3.4.1 Bayer - Company Business Overview

      • 3.4.2 Bayer - Company Financial Performance

      • 3.4.3 Bayer - Company Financial Performance of Opioid-Induced Constipation

      • 3.4.4 Opioid-Induced Constipation Product Benchmarking

      • 3.4.5 Strategic Initiatives

    • 3.5 GSK

      • 3.5.1 GSK - Company Business Overview

      • 3.5.2 GSK - Company Financial Performance

      • 3.5.3 GSK - Company Financial Performance of Opioid-Induced Constipation

      • 3.5.4 Opioid-Induced Constipation Product Benchmarking

      • 3.5.5 Strategic Initiatives

    • 3.6 Sanofi

      • 3.6.1 Sanofi - Company Business Overview

      • 3.6.2 Sanofi - Company Financial Performance

      • 3.6.3 Sanofi - Company Financial Performance of Opioid-Induced Constipation

      • 3.6.4 Opioid-Induced Constipation Product Benchmarking

      • 3.6.5 Strategic Initiatives

    • 3.7 Daiichi Sankyo

      • 3.7.1 Daiichi Sankyo - Company Business Overview

      • 3.7.2 Daiichi Sankyo - Company Financial Performance

      • 3.7.3 Daiichi Sankyo - Company Financial Performance of Opioid-Induced Constipation

      • 3.7.4 Opioid-Induced Constipation Product Benchmarking

      • 3.7.5 Strategic Initiatives

    • 3.8 Takeda Pharmaceuticals

      • 3.8.1 Takeda Pharmaceuticals - Company Business Overview

      • 3.8.2 Takeda Pharmaceuticals - Company Financial Performance

      • 3.8.3 Takeda Pharmaceuticals - Company Financial Performance of Opioid-Induced Constipation

      • 3.8.4 Opioid-Induced Constipation Product Benchmarking

      • 3.8.5 Strategic Initiatives

    • 3.9 Purdue Pharm

      • 3.9.1 Purdue Pharm - Company Business Overview

      • 3.9.2 Purdue Pharm - Company Financial Performance

      • 3.9.3 Purdue Pharm - Company Financial Performance of Opioid-Induced Constipation

      • 3.9.4 Opioid-Induced Constipation Product Benchmarking

      • 3.9.5 Strategic Initiatives

    • 3.10 Nektar Therapeutics

      • 3.10.1 Nektar Therapeutics - Company Business Overview

      • 3.10.2 Nektar Therapeutics - Company Financial Performance

      • 3.10.3 Nektar Therapeutics - Company Financial Performance of Opioid-Induced Constipation

      • 3.10.4 Opioid-Induced Constipation Product Benchmarking

      • 3.10.5 Strategic Initiatives

    • 3.11 Shionogi

      • 3.11.1 Shionogi - Company Business Overview

      • 3.11.2 Shionogi - Company Financial Performance

      • 3.11.3 Shionogi - Company Financial Performance of Opioid-Induced Constipation

      • 3.11.4 Opioid-Induced Constipation Product Benchmarking

      • 3.11.5 Strategic Initiatives

    • 3.12 Prestige

      • 3.12.1 Prestige - Company Business Overview

      • 3.12.2 Prestige - Company Financial Performance

      • 3.12.3 Prestige - Company Financial Performance of Opioid-Induced Constipation

      • 3.12.4 Opioid-Induced Constipation Product Benchmarking

      • 3.12.5 Strategic Initiatives

    • 3.13 Mallinckrodt

      • 3.13.1 Mallinckrodt - Company Business Overview

      • 3.13.2 Mallinckrodt - Company Financial Performance

      • 3.13.3 Mallinckrodt - Company Financial Performance of Opioid-Induced Constipation

      • 3.13.4 Opioid-Induced Constipation Product Benchmarking

      • 3.13.5 Strategic Initiatives

    4 Global Opioid-Induced Constipation Market Segment Analysis (Types Level)

    • 4.1 Purchasing Strategy based on Purchasing Positioning Model

    • 4.2 Global Opioid-Induced Constipation Market Revenue and Market Share by Types (Historical)

      • 4.2.1 Global Revenue and Growth Rate of Methylnaltrexone Bromide 2016-2021

      • 4.2.2 Global Revenue and Growth Rate of Lubiprostone 2016-2021

      • 4.2.3 Global Revenue and Growth Rate of Naloxegol 2016-2021

      • 4.2.4 Global Revenue and Growth Rate of Others 2016-2021

    • 4.3 Global Opioid-Induced Constipation Market Sales and Market Share by Types (Historical)

      • 4.3.1 Global Sales and Growth Rate of Methylnaltrexone Bromide 2016-2021

      • 4.3.2 Global Sales and Growth Rate of Lubiprostone 2016-2021

      • 4.3.3 Global Sales and Growth Rate of Naloxegol 2016-2021

      • 4.3.4 Global Sales and Growth Rate of Others 2016-2021

    • 4.4 Global Opioid-Induced Constipation Market Revenue and Market Share by Types (Forecast)

    • 4.5 Global Opioid-Induced Constipation Market Sales and Market Share by Types (Forecast)

    • 4.6 Global Opioid-Induced Constipation Market Price By Type from 2016 to 2026

    5 Global Opioid-Induced Constipation Market Segment Analysis (Application Level)

    • 5.1 Downstream Industry Demand Analysis of Opioid-Induced Constipation

    • 5.2 Global Opioid-Induced Constipation Market Revenue and Market Share by Application (Historical)

      • 5.2.1 Global Revenue and Growth Rate of Hospital 2016-2021

      • 5.2.2 Global Revenue and Growth Rate of Pharmacy 2016-2021

    • 5.3 Global Opioid-Induced Constipation Market Sales and Market Share by Application (Historical)

      • 5.3.1 Global Sales and Growth Rate of Hospital 2016-2021

      • 5.3.2 Global Sales and Growth Rate of Pharmacy 2016-2021

    • 5.4 Global Opioid-Induced Constipation Market Revenue and Market Share by Application (Forecast)

    • 5.5 Global Opioid-Induced Constipation Market Sales and Market Share by Application (Forecast)

    6 Global Opioid-Induced Constipation Market Segment Analysis (Geography Level)

    • 6.1 Global Opioid-Induced Constipation Market Revenue and Market Share by Geography (Historical)

    • 6.2 Global Opioid-Induced Constipation Market Sales and Market Share by Geography (Historical)

    • 6.3 Global Opioid-Induced Constipation Market Revenue and Market Share by Geography (Forecast)

    • 6.4 Global Opioid-Induced Constipation Market Sales and Market Share by Geography (Forecast)

    • 6.5 Top Sales Country Advantage Analysis

    • 6.6 Top 5 Export Countries in Opioid-Induced Constipation Market from 2016 to 2020

    • 6.7 Top 5 Import Countries in Opioid-Induced Constipation Market from 2016 to 2020

    7. North America Opioid-Induced Constipation Market Segment Analysis and Investment Attractiveness

    • 7.1 North America Opioid-Induced Constipation Market Segment by Countries

      • 7.1.1 North America Opioid-Induced Constipation Market Revenue Segment by Countries

      • 7.1.2 North America Opioid-Induced Constipation Market Sales Segment by Countries

      • 7.1.3 USA

      • 7.1.4 Canada

      • 7.1.5 Mexico

    • 7.2 North America Opioid-Induced Constipation Market Segment (Product Type Level)

    • 7.3 North America Opioid-Induced Constipation Market Segment (Application/Industry Level)

    • 7.4 Key Country Economy in North America

    • 7.5 Analysis of Investment Attractiveness of Major Countries

    8 Europe Opioid-Induced Constipation Market Segment Analysis and Investment Attractiveness

    • 8.1 Europe Opioid-Induced Constipation Market Segment by Countries

      • 8.1.1 Europe Opioid-Induced Constipation Market Revenue Segment by Countries

      • 8.1.2 Europe Opioid-Induced Constipation Market Sales Segment by Countries

      • 8.1.3 Germany

      • 8.1.4 United Kingdom

      • 8.1.5 France

      • 8.1.6 Italy

      • 8.1.7 Russia

      • 8.1.8 Spain

      • 8.1.9 Netherlands

      • 8.1.10 Switzerland

      • 8.1.11 Turkey

      • 8.1.12 Poland

      • 8.1.13 Sweden

      • 8.1.14 Belgium

      • 8.1.15 Austria

      • 8.1.16 Others

    • 8.2 Europe Opioid-Induced Constipation Market Segment (Product Type Level)

    • 8.3 Europe Opioid-Induced Constipation Market Segment (Application/Industry Level)

    • 8.4 Key Country Economy in Europe

    • 8.5 Analysis of Investment Attractiveness of Major Countries

    9 Asia Opioid-Induced Constipation Market Segment Analysis and Investment Attractiveness

    • 9.1 Asia Opioid-Induced Constipation Market Segment by Countries

      • 9.1.1 Asia Opioid-Induced Constipation Market Revenue Segment by Countries

      • 9.1.2 Asia Opioid-Induced Constipation Market Sales Segment by Countries

      • 9.1.3 China

      • 9.1.4 Japan

      • 9.1.5 India

      • 9.1.6 South Korea

      • 9.1.7 Malaysia

      • 9.1.8 Vietnam

      • 9.1.9 Philippines

      • 9.1.10 Singapore

      • 9.1.11 Thailand

      • 9.1.12 Others

    • 9.2 Asia Opioid-Induced Constipation Market Segment (Product Type Level)

    • 9.3 Asia Opioid-Induced Constipation Market Segment (Application/Industry Level)

    • 9.4 Key Country Economy in Asia Pacific

    • 9.5 Analysis of Investment Attractiveness of Major Countries

    10 South America Opioid-Induced Constipation Market Segment Analysis and Investment Attractiveness

    • 10.1 South America Opioid-Induced Constipation Market Segment by Countries

      • 10.1.1 South America Opioid-Induced Constipation Market Revenue Segment by Countries

      • 10.1.2 South America Opioid-Induced Constipation Market Sales Segment by Countries

      • 10.1.3 Brazil

      • 10.1.4 Argentina

      • 10.1.5 Colombia

      • 10.1.6 Chile

      • 10.1.7 Others

    • 10.2 South America Opioid-Induced Constipation Market Segment (Product Type Level)

    • 10.3 South America Opioid-Induced Constipation Market Segment (Application/Industry Level)

    • 10.4 Key Country Economy in Asia Pacific

    • 10.5 Analysis of Investment Attractiveness of Major Countries

    11 Middle East Opioid-Induced Constipation Market Segment Analysis and Investment Attractiveness

    • 11.1 Middle East Opioid-Induced Constipation Market Segment by Countries

      • 11.1.1 Middle East Opioid-Induced Constipation Market Revenue Segment by Countries

      • 11.1.2 Middle East Opioid-Induced Constipation Market Sales Segment by Countries

      • 11.1.3 United Arab Emirates (UAE)

      • 11.1.4 Saudi Arabia

      • 11.1.5 Others

    • 11.2 Middle East Opioid-Induced Constipation Market Segment (Product Type Level)

    • 11.3 Middle East Opioid-Induced Constipation Market Segment (Application/Industry Level)

    • 11.4 Key Country Economy in Middle East

    • 11.5 Analysis of Investment Attractiveness of Major Countries

    12 Africa Opioid-Induced Constipation Market Segment Analysis and Investment Attractiveness

    • 12.1 Africa Opioid-Induced Constipation Market Segment by Countries

      • 12.1.1 Africa Opioid-Induced Constipation Market Revenue Segment by Countries

      • 12.1.2 Africa Opioid-Induced Constipation Market Sales Segment by Countries

      • 12.1.3 Nigeria

      • 12.1.4 Egypt

      • 12.1.5 South Africa

      • 12.1.6 Others

    • 12.2 Africa Opioid-Induced Constipation Market Segment (Product Type Level)

    • 12.3 Africa Opioid-Induced Constipation Market Segment (Application/Industry Level)

    • 12.4 Key Country Economy in Africa

    • 12.5 Analysis of Investment Attractiveness of Major Countries

    13 Oceania Opioid-Induced Constipation Market Segment Analysis and Investment Attractiveness

    • 13.1 Oceania Opioid-Induced Constipation Market Segment by Countries

      • 13.1.1 Oceania Opioid-Induced Constipation Market Revenue Segment by Countries

      • 13.1.2 Oceania Opioid-Induced Constipation Market Sales Segment by Countries

      • 13.1.3 Australia

      • 13.1.4 New Zealand

      • 13.1.5 Others

    • 13.2 Oceania Opioid-Induced Constipation Market Segment (Product Type Level)

    • 13.3 Oceania Opioid-Induced Constipation Market Segment (Application/Industry Level)

    • 13.4 Key Country Economy in Oceania

    • 13.5 Analysis of Investment Attractiveness of Major Countries

    14 Supply Chain Analysis

    • 14.1 Upstream Market Analysis

      • 14.1.1 Key Raw Materials Production Base and Market Concentration Rate

      • 14.1.2 Key Raw Materials Price Trend

    • 14.2 Opioid-Induced Constipation Production Analysis

      • 14.2.1 Manufacturing Cost Structure of Opioid-Induced Constipation

      • 14.2.2 Manufacturing Process Analysis of Opioid-Induced Constipation

      • 14.2.3 Source of Technology

      • 14.2.4 Competitive Landscape

    • 14.3 Downstream Market Analysis

      • 14.3.1 Customer Positioning Analysis

      • 14.3.2 Major Downstream Buyers of Opioid-Induced Constipation Analysis

    15 Market Influences Factors Analysis

    • 15.1 Changes from the Related Industries

    • 15.2 Substitutes Threat

    • 15.3 Customer Preference Change

    • 15.4 Upstream and Downstream Fluctuation

    • 15.5 COVID-19 Impact

      • 15.5.1 COVID-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections

      • 15.5.2 Opioid-Induced Constipation Industry Market Status, Pre-COVID-19

      • 15.5.3 Opioid-Induced Constipation Industry Market Status, Post-COVID-19

      • 15.5.4 Impact of COVID-19 on Supply Chain

    • 15.6 Post-COVID-19 Opioid-Induced Constipation Industry Opportunity

    16 Key Research Findings


    The List of Tables and Figures

    • Figure Opioid-Induced Constipation Product Picture

    • Table Opioid-Induced Constipation Product Definition

    • Table Study Scope by Types

    • Figure Global Opioid-Induced Constipation Market Value by Type (2016 - 2026)

    • Table Study Scope by Application

    • Figure Global Opioid-Induced Constipation Market Value by Application (2016 - 2026)

    • Figure Global Opioid-Induced Constipation Market Size and Growth Rate from 2016 to 2026

    • Table Global Opioid-Induced Constipation Production Capacity by Manufacturers (2016-2021)

    • Table Global Opioid-Induced Constipation Production Capacity Market Share by Manufacturers (2016-2021)

    • Table Global Opioid-Induced Constipation Revenue by Manufacturers (2016-2021)

    • Table Global Opioid-Induced Constipation Revenue Market Share by Manufacturers (2016-2021)

    • Table Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

    • Table Manufacturers Opioid-Induced Constipation Plant Distribution and Sales Country

    • Table AstraZeneca - Company Business Overview

    • Figure AstraZeneca Total Revenue from 2018 to 2020

    • Table AstraZeneca Sales, Revenue, Average Price and Gross Margin Analysis

    • Figure AstraZeneca Sales and Growth Rate Analysis of Opioid-Induced Constipation

    • Figure Revenue and Market Share Analysis of AstraZeneca

    • Table Opioid-Induced Constipation Product Benchmarking

    • Table Salix (Bausch Health) - Company Business Overview

    • Figure Salix (Bausch Health) Total Revenue from 2018 to 2020

    • Table Salix (Bausch Health) Sales, Revenue, Average Price and Gross Margin Analysis

    • Figure Salix (Bausch Health) Sales and Growth Rate Analysis of Opioid-Induced Constipation

    • Figure Revenue and Market Share Analysis of Salix (Bausch Health)

    • Table Opioid-Induced Constipation Product Benchmarking

    • Table Progenics Pharmaceuticals - Company Business Overview

    • Figure Progenics Pharmaceuticals Total Revenue from 2018 to 2020

    • Table Progenics Pharmaceuticals Sales, Revenue, Average Price and Gross Margin Analysis

    • Figure Progenics Pharmaceuticals Sales and Growth Rate Analysis of Opioid-Induced Constipation

    • Figure Revenue and Market Share Analysis of Progenics Pharmaceuticals

    • Table Opioid-Induced Constipation Product Benchmarking

    • Table Bayer - Company Business Overview

    • Figure Bayer Total Revenue from 2018 to 2020

    • Table Bayer Sales, Revenue, Average Price and Gross Margin Analysis

    • Figure Bayer Sales and Growth Rate Analysis of Opioid-Induced Constipation

    • Figure Revenue and Market Share Analysis of Bayer

    • Table Opioid-Induced Constipation Product Benchmarking

    • Table GSK - Company Business Overview

    • Figure GSK Total Revenue from 2018 to 2020

    • Table GSK Sales, Revenue, Average Price and Gross Margin Analysis

    • Figure GSK Sales and Growth Rate Analysis of Opioid-Induced Constipation

    • Figure Revenue and Market Share Analysis of GSK

    • Table Opioid-Induced Constipation Product Benchmarking

    • Table Sanofi - Company Business Overview

    • Figure Sanofi Total Revenue from 2018 to 2020

    • Table Sanofi Sales, Revenue, Average Price and Gross Margin Analysis

    • Figure Sanofi Sales and Growth Rate Analysis of Opioid-Induced Constipation

    • Figure Revenue and Market Share Analysis of Sanofi

    • Table Opioid-Induced Constipation Product Benchmarking

    • Table Daiichi Sankyo - Company Business Overview

    • Figure Daiichi Sankyo Total Revenue from 2018 to 2020

    • Table Daiichi Sankyo Sales, Revenue, Average Price and Gross Margin Analysis

    • Figure Daiichi Sankyo Sales and Growth Rate Analysis of Opioid-Induced Constipation

    • Figure Revenue and Market Share Analysis of Daiichi Sankyo

    • Table Opioid-Induced Constipation Product Benchmarking

    • Table Takeda Pharmaceuticals - Company Business Overview

    • Figure Takeda Pharmaceuticals Total Revenue from 2018 to 2020

    • Table Takeda Pharmaceuticals Sales, Revenue, Average Price and Gross Margin Analysis

    • Figure Takeda Pharmaceuticals Sales and Growth Rate Analysis of Opioid-Induced Constipation

    • Figure Revenue and Market Share Analysis of Takeda Pharmaceuticals

    • Table Opioid-Induced Constipation Product Benchmarking

    • Table Purdue Pharm - Company Business Overview

    • Figure Purdue Pharm Total Revenue from 2018 to 2020

    • Table Purdue Pharm Sales, Revenue, Average Price and Gross Margin Analysis

    • Figure Purdue Pharm Sales and Growth Rate Analysis of Opioid-Induced Constipation

    • Figure Revenue and Market Share Analysis of Purdue Pharm

    • Table Opioid-Induced Constipation Product Benchmarking

    • Table Nektar Therapeutics - Company Business Overview

    • Figure Nektar Therapeutics Total Revenue from 2018 to 2020

    • Table Nektar Therapeutics Sales, Revenue, Average Price and Gross Margin Analysis

    • Figure Nektar Therapeutics Sales and Growth Rate Analysis of Opioid-Induced Constipation

    • Figure Revenue and Market Share Analysis of Nektar Therapeutics

    • Table Opioid-Induced Constipation Product Benchmarking

    • Table Shionogi - Company Business Overview

    • Figure Shionogi Total Revenue from 2018 to 2020

    • Table Shionogi Sales, Revenue, Average Price and Gross Margin Analysis

    • Figure Shionogi Sales and Growth Rate Analysis of Opioid-Induced Constipation

    • Figure Revenue and Market Share Analysis of Shionogi

    • Table Opioid-Induced Constipation Product Benchmarking

    • Table Prestige - Company Business Overview

    • Figure Prestige Total Revenue from 2018 to 2020

    • Table Prestige Sales, Revenue, Average Price and Gross Margin Analysis

    • Figure Prestige Sales and Growth Rate Analysis of Opioid-Induced Constipation

    • Figure Revenue and Market Share Analysis of Prestige

    • Table Opioid-Induced Constipation Product Benchmarking

    • Table Mallinckrodt - Company Business Overview

    • Figure Mallinckrodt Total Revenue from 2018 to 2020

    • Table Mallinckrodt Sales, Revenue, Average Price and Gross Margin Analysis

    • Figure Mallinckrodt Sales and Growth Rate Analysis of Opioid-Induced Constipation

    • Figure Revenue and Market Share Analysis of Mallinckrodt

    • Table Opioid-Induced Constipation Product Benchmarking

    • Table Purchasing Strategy based on Purchasing Positioning Model

    • Table Global Opioid-Induced Constipation Market Revenue by Types (Historical)

    • Table Global Opioid-Induced Constipation Market Revenue Market Share by Types (Historical)

    • Figure Global Revenue and Growth Rate of Methylnaltrexone Bromide 2016-2021

    • Figure Global Revenue and Growth Rate of Lubiprostone 2016-2021

    • Figure Global Revenue and Growth Rate of Naloxegol 2016-2021

    • Figure Global Revenue and Growth Rate of Others 2016-2021

    • Table Global Opioid-Induced Constipation Market Sales by Types (Historical)

    • Table Global Opioid-Induced Constipation Market Sales Market Share by Types (Historical)

    • Figure Global Sales and Growth Rate of Methylnaltrexone Bromide 2016-2021

    • Figure Global Sales and Growth Rate of Lubiprostone 2016-2021

    • Figure Global Sales and Growth Rate of Naloxegol 2016-2021

    • Figure Global Sales and Growth Rate of Others 2016-2021

    • Table Global Opioid-Induced Constipation Market Revenue by Types (Forecast)

    • Table Global Opioid-Induced Constipation Market Revenue Market Share by Types (Forecast)

    • Table Global Opioid-Induced Constipation Market Sales by Types (Forecast)

    • Table Global Opioid-Induced Constipation Market Sales Market Share by Types (Forecast)

    • Figure Global Opioid-Induced Constipation Market Price By Type from 2016 to 2026

    • Table Downstream Industry Demand Analysis for Opioid-Induced Constipation

    • Table Global Opioid-Induced Constipation Market Revenue by Application (Historical)

    • Table Global Opioid-Induced Constipation Market Revenue Market Share by Application (Historical)

    • Figure Global Revenue and Growth Rate of Hospital 2016-2021

    • Figure Global Revenue and Growth Rate of Pharmacy 2016-2021

    • Table Global Opioid-Induced Constipation Market Sales by Application (Historical)

    • Table Global Opioid-Induced Constipation Market Sales Market Share by Application (Historical)

    • Figure Global Sales and Growth Rate of Hospital 2016-2021

    • Figure Global Sales and Growth Rate of Pharmacy 2016-2021

    • Table Global Opioid-Induced Constipation Market Revenue by Application (Forecast)

    • Table Global Opioid-Induced Constipation Market Revenue Market Share by Application (Forecast)

    • Table Global Opioid-Induced Constipation Market Sales by Application (Forecast)

    • Table Global Opioid-Induced Constipation Market Sales Market Share by Application (Forecast)

    • Table Global Opioid-Induced Constipation Market Revenue by Geography (Historical)

    • Table Global Opioid-Induced Constipation Market Revenue Market Share by Geography (Historical)

    • Figure Global Opioid-Induced Constipation Revenue Market Share by Geography in 2020

    • Table Global Opioid-Induced Constipation Market Sales by Geography (Historical)

    • Table Global Opioid-Induced Constipation Market Sales Market Share by Geography (Historical)

    • Figure Global Opioid-Induced Constipation Sales Market Share by Geography in 2020

    • Table Global Opioid-Induced Constipation Market Revenue by Geography (Forecast)

    • Table Global Opioid-Induced Constipation Market Revenue Market Share by Geography (Forecast)

    • Table Global Opioid-Induced Constipation Market Sales by Geography (Forecast)

    • Table Global Opioid-Induced Constipation Market Sales Market Share by Geography (Forecast)

    • Figure Top Sales Country Geographical Advantage Analysis

    • Table North America Opioid-Induced Constipation Revenue by Countries from 2016 to 2026

    • Table North America Opioid-Induced Constipation Revenue Market Share by Countries from 2016 to 2026

    • Figure North America Opioid-Induced Constipation Revenue Market Share by Major Countries in 2020

    • Table North America Opioid-Induced Constipation Sales by Countries from 2016 to 2026

    • Table North America Opioid-Induced Constipation Sales Market Share by Countries from 2016 to 2026

    • Figure North America Opioid-Induced Constipation Sales Market Share by Major Countries in 2020

    • Figure USA Opioid-Induced Constipation Market Value and Growth Rate from 2016 to 2026

    • Figure USA Opioid-Induced Constipation Market Volume and Growth Rate from 2016 to 2026

    • Figure Canada Opioid-Induced Constipation Market Value and Growth Rate from 2016 to 2026

    • Figure Canada Opioid-Induced Constipation Market Volume and Growth Rate from 2016 to 2026

    • Figure Mexico Opioid-Induced Constipation Market Value and Growth Rate from 2016 to 2026

    • Figure Mexico Opioid-Induced Constipation Market Volume and Growth Rate from 2016 to 2026

    • Table North America Opioid-Induced Constipation Sales by Types from 2016 to 2026

    • Table North America Opioid-Induced Constipation Sales Market Share by Types from 2016 to 2026

    • Table North America Opioid-Induced Constipation Value by Types from 2016 to 2026

    • Table North America Opioid-Induced Constipation Value Market Share by Types from 2016 to 2026

    • Table North America Opioid-Induced Constipation Sales by Application from 2016 to 2026

    • Table North America Opioid-Induced Constipation Sales Market Share by Application from 2016 to 2026

    • Table North America Opioid-Induced Constipation Value by Application from 2016 to 2026

    • Table North America Opioid-Induced Constipation Value Market Share by Application from 2016 to 2026

    • Table Europe Opioid-Induced Constipation Revenue by Countries from 2016 to 2026

    • Table Europe Opioid-Induced Constipation Revenue Market Share by Countries from 2016 to 2026

    • Figure Europe Opioid-Induced Constipation Revenue Market Share by Major Countries in 2020

    • Table Europe Opioid-Induced Constipation Sales by Countries from 2016 to 2026

    • Table Europe Opioid-Induced Constipation Sales Market Share by Countries from 2016 to 2026

    • Figure Europe Opioid-Induced Constipation Sales Market Share by Major Countries in 2020

    • Figure Germany Opioid-Induced Constipation Market Value and Growth Rate from 2016 to 2026

    • Figure Germany Opioid-Induced Constipation Market Volume and Growth Rate from 2016 to 2026

    • Figure United Kingdom Opioid-Induced Constipation Market Value and Growth Rate from 2016 to 2026

    • Figure United Kingdom Opioid-Induced Constipation Market Volume and Growth Rate from 2016 to 2026

    • Figure France Opioid-Induced Constipation Market Value and Growth Rate from 2016 to 2026

    • Figure France Opioid-Induced Constipation Market Volume and Growth Rate from 2016 to 2026

    • Figure Italy Opioid-Induced Constipation Market Value and Growth Rate from 2016 to 2026

    • Figure Italy Opioid-Induced Constipation Market Volume and Growth Rate from 2016 to 2026

    • Figure Russia Opioid-Induced Constipation Market Value and Growth Rate from 2016 to 2026

    • Figure Russia Opioid-Induced Constipation Market Volume and Growth Rate from 2016 to 2026

    • Figure Spain Opioid-Induced Constipation Market Value and Growth Rate from 2016 to 2026

    • Figure Spain Opioid-Induced Constipation Market Volume and Growth Rate from 2016 to 2026

    • Figure Netherlands Opioid-Induced Constipation Market Value and Growth Rate from 2016 to 2026

    • Figure Netherlands Opioid-Induced Constipation Market Volume and Growth Rate from 2016 to 2026

    • Figure Switzerland Opioid-Induced Constipation Market Value and Growth Rate from 2016 to 2026

    • Figure Switzerland Opioid-Induced Constipation Market Volume and Growth Rate from 2016 to 2026

    • Figure Turkey Opioid-Induced Constipation Market Value and Growth Rate from 2016 to 2026

    • Figure Turkey Opioid-Induced Constipation Market Volume and Growth Rate from 2016 to 2026

    • Figure Poland Opioid-Induced Constipation Market Value and Growth Rate from 2016 to 2026

    • Figure Poland Opioid-Induced Constipation Market Volume and Growth Rate from 2016 to 2026

    • Figure Sweden Opioid-Induced Constipation Market Value and Growth Rate from 2016 to 2026

    • Figure Sweden Opioid-Induced Constipation Market Volume and Growth Rate from 2016 to 2026

    • Figure Belgium Opioid-Induced Constipation Market Value and Growth Rate from 2016 to 2026

    • Figure Belgium Opioid-Induced Constipation Market Volume and Growth Rate from 2016 to 2026

    • Figure Austria Opioid-Induced Constipation Market Value and Growth Rate from 2016 to 2026

    • Figure Austria Opioid-Induced Constipation Market Volume and Growth Rate from 2016 to 2026

    • Figure Others Opioid-Induced Constipation Market Value and Growth Rate from 2016 to 2026

    • Figure Others Opioid-Induced Constipation Market Volume and Growth Rate from 2016 to 2026

    • Table Europe Opioid-Induced Constipation Sales by Types from 2016 to 2026

    • Table Europe Opioid-Induced Constipation Sales Market Share by Types from 2016 to 2026

    • Table Europe Opioid-Induced Constipation Value by Types from 2016 to 2026

    • Table Europe Opioid-Induced Constipation Value Market Share by Types from 2016 to 2026

    • Table Europe Opioid-Induced Constipation Sales by Application from 2016 to 2026

    • Table Europe Opioid-Induced Constipation Sales Market Share by Application from 2016 to 2026

    • Table Europe Opioid-Induced Constipation Value by Application from 2016 to 2026

    • Table Europe Opioid-Induced Constipation Value Market Share by Application from 2016 to 2026

    • Table Asia Opioid-Induced Constipation Revenue by Countries from 2016 to 2026

    • Table Asia Opioid-Induced Constipation Revenue Market Share by Countries from 2016 to 2026

    • Figure Asia Opioid-Induced Constipation Revenue Market Share by Major Countries in 2020

    • Table Asia Opioid-Induced Constipation Sales by Countries from 2016 to 2026

    • Table Asia Opioid-Induced Constipation Sales Market Share by Countries from 2016 to 2026

    • Figure Asia Opioid-Induced Constipation Sales Market Share by Major Countries in 2020

    • Figure China Opioid-Induced Constipation Market Value and Growth Rate from 2016 to 2026

    • Figure China Opioid-Induced Constipation Market Volume and Growth Rate from 2016 to 2026

    • Figure Japan Opioid-Induced Constipation Market Value and Growth Rate from 2016 to 2026

    • Figure Japan Opioid-Induced Constipation Market Volume and Growth Rate from 2016 to 2026

    • Figure India Opioid-Induced Constipation Market Value and Growth Rate from 2016 to 2026

    • Figure India Opioid-Induced Constipation Market Volume and Growth Rate from 2016 to 2026

    • Figure South Korea Opioid-Induced Constipation Market Value and Growth Rate from 2016 to 2026

    • Figure South Korea Opioid-Induced Constipation Market Volume and Growth Rate from 2016 to 2026

    • Figure Malaysia Opioid-Induced Constipation Market Value and Growth Rate from 2016 to 2026

    • Figure Malaysia Opioid-Induced Constipation Market Volume and Growth Rate from 2016 to 2026

    • Figure Vietnam Opioid-Induced Constipation Market Value and Growth Rate from 2016 to 2026

    • Figure Vietnam Opioid-Induced Constipation Market Volume and Growth Rate from 2016 to 2026

    • Figure Philippines Opioid-Induced Constipation Market Value and Growth Rate from 2016 to 2026

    • Figure Philippines Opioid-Induced Constipation Market Volume and Growth Rate from 2016 to 2026

    • Figure Singapore Opioid-Induced Constipation Market Value and Growth Rate from 2016 to 2026

    • Figure Singapore Opioid-Induced Constipation Market Volume and Growth Rate from 2016 to 2026

    • Figure Thailand Opioid-Induced Constipation Market Value and Growth Rate from 2016 to 2026

    • Figure Thailand Opioid-Induced Constipation Market Volume and Growth Rate from 2016 to 2026

    • Figure Others Opioid-Induced Constipation Market Value and Growth Rate from 2016 to 2026

    • Figure Others Opioid-Induced Constipation Market Volume and Growth Rate from 2016 to 2026

    • Table Asia Opioid-Induced Constipation Sales by Types from 2016 to 2026

    • Table Asia Opioid-Induced Constipation Sales Market Share by Types from 2016 to 2026

    • Table Asia Opioid-Induced Constipation Value by Types from 2016 to 2026

    • Table Asia Opioid-Induced Constipation Value Market Share by Types from 2016 to 2026

    • Table Asia Opioid-Induced Constipation Sales by Application from 2016 to 2026

    • Table Asia Opioid-Induced Constipation Sales Market Share by Application from 2016 to 2026

    • Table Asia Opioid-Induced Constipation Value by Application from 2016 to 2026

    • Table Asia Opioid-Induced Constipation Value Market Share by Application from 2016 to 2026

    • Table South America Opioid-Induced Constipation Revenue by Countries from 2016 to 2026

    • Table South America Opioid-Induced Constipation Revenue Market Share by Countries from 2016 to 2026

    • Figure South America Opioid-Induced Constipation Revenue Market Share by Major Countries in 2020

    • Table South America Opioid-Induced Constipation Sales by Countries from 2016 to 2026

    • Table South America Opioid-Induced Constipation Sales Market Share by Countries from 2016 to 2026

    • Figure South America Opioid-Induced Constipation Sales Market Share by Major Countries in 2020

    • Figure Brazil Opioid-Induced Constipation Market Value and Growth Rate from 2016 to 2026

    • Figure Brazil Opioid-Induced Constipation Market Volume and Growth Rate from 2016 to 2026

    • Figure Argentina Opioid-Induced Constipation Market Value and Growth Rate from 2016 to 2026

    • Figure Argentina Opioid-Induced Constipation Market Volume and Growth Rate from 2016 to 2026

    • Figure Colombia Opioid-Induced Constipation Market Value and Growth Rate from 2016 to 2026

    • Figure Colombia Opioid-Induced Constipation Market Volume and Growth Rate from 2016 to 2026

    • Figure Chile Opioid-Induced Constipation Market Value and Growth Rate from 2016 to 2026

    • Figure Chile Opioid-Induced Constipation Market Volume and Growth Rate from 2016 to 2026

    • Figure Others Opioid-Induced Constipation Market Value and Growth Rate from 2016 to 2026

    • Figure Others Opioid-Induced Constipation Market Volume and Growth Rate from 2016 to 2026

    • Table South America Opioid-Induced Constipation Sales by Types from 2016 to 2026

    • Table South America Opioid-Induced Constipation Sales Market Share by Types from 2016 to 2026

    • Table South America Opioid-Induced Constipation Value by Types from 2016 to 2026

    • Table South America Opioid-Induced Constipation Value Market Share by Types from 2016 to 2026

    • Table South America Opioid-Induced Constipation Sales by Application from 2016 to 2026

    • Table South America Opioid-Induced Constipation Sales Market Share by Application from 2016 to 2026

    • Table South America Opioid-Induced Constipation Value by Application from 2016 to 2026

    • Table South America Opioid-Induced Constipation Value Market Share by Application from 2016 to 2026

    • Table Middle East Opioid-Induced Constipation Revenue by Countries from 2016 to 2026

    • Table Middle East Opioid-Induced Constipation Revenue Market Share by Countries from 2016 to 2026

    • Figure Middle East Opioid-Induced Constipation Revenue Market Share by Major Countries in 2020

    • Table Middle East Opioid-Induced Constipation Sales by Countries from 2016 to 2026

    • Table Middle East Opioid-Induced Constipation Sales Market Share by Countries from 2016 to 2026

    • Figure Middle East Opioid-Induced Constipation Sales Market Share by Major Countries in 2020

    • Figure United Arab Emirates (UAE) Opioid-Induced Constipation Market Value and Growth Rate from 2016 to 2026

    • Figure United Arab Emirates (UAE) Opioid-Induced Constipation Market Volume and Growth Rate from 2016 to 2026

    • Figure Saudi Arabia Opioid-Induced Constipation Market Value and Growth Rate from 2016 to 2026

    • Figure Saudi Arabia Opioid-Induced Constipation Market Volume and Growth Rate from 2016 to 2026

    • Figure Others Opioid-Induced Constipation Market Value and Growth Rate from 2016 to 2026

    • Figure Others Opioid-Induced Constipation Market Volume and Growth Rate from 2016 to 2026

    • Table Middle East Opioid-Induced Constipation Sales by Types from 2016 to 2026

    • Table Middle East Opioid-Induced Constipation Sales Market Share by Types from 2016 to 2026

    • Table Middle East Opioid-Induced Constipation Value by Types from 2016 to 2026

    • Table Middle East Opioid-Induced Constipation Value Market Share by Types from 2016 to 2026

    • Table Middle East Opioid-Induced Constipation Sales by Application from 2016 to 2026

    • Table Middle East Opioid-Induced Constipation Sales Market Share by Application from 2016 to 2026

    • Table Middle East Opioid-Induced Constipation Value by Application from 2016 to 2026

    • Table Middle East Opioid-Induced Constipation Value Market Share by Application from 2016 to 2026

    • Table Africa Opioid-Induced Constipation Revenue by Countries from 2016 to 2026

    • Table Africa Opioid-Induced Constipation Revenue Market Share by Countries from 2016 to 2026

    • Figure Africa Opioid-Induced Constipation Revenue Market Share by Major Countries in 2020

    • Table Africa Opioid-Induced Constipation Sales by Countries from 2016 to 2026

    • Table Africa Opioid-Induced Constipation Sales Market Share by Countries from 2016 to 2026

      • Figure Africa Opioid-Induced Constipation Sales Market Share by Major Countries in 2020

    • Figure Nigeria Opioid-Induced Constipation Market Value and Growth Rate from 2016 to 2026

    • Figure Nigeria Opioid-Induced Constipation Market Volume and Growth Rate from 2016 to 2026

    • Figure Egypt Opioid-Induced Constipation Market Value and Growth Rate from 2016 to 2026

    • Figure Egypt Opioid-Induced Constipation Market Volume and Growth Rate from 2016 to 2026

    • Figure South Africa Opioid-Induced Constipation Market Value and Growth Rate from 2016 to 2026

    • Figure South Africa Opioid-Induced Constipation Market Volume and Growth Rate from 2016 to 2026

    • Figure Others Opioid-Induced Constipation Market Value and Growth Rate from 2016 to 2026

    • Figure Others Opioid-Induced Constipation Market Volume and Growth Rate from 2016 to 2026

    • Table Africa Opioid-Induced Constipation Sales by Types from 2016 to 2026

    • Table Africa Opioid-Induced Constipation Sales Market Share by Types from 2016 to 2026

    • Table Africa Opioid-Induced Constipation Value by Types from 2016 to 2026

    • Table Africa Opioid-Induced Constipation Value Market Share by Types from 2016 to 2026

    • Table Africa Opioid-Induced Constipation Sales by Application from 2016 to 2026

    • Table Africa Opioid-Induced Constipation Sales Market Share by Application from 2016 to 2026

    • Table Africa Opioid-Induced Constipation Value by Application from 2016 to 2026

    • Table Africa Opioid-Induced Constipation Value Market Share by Application from 2016 to 2026

    • Table Oceania Opioid-Induced Constipation Revenue by Countries from 2016 to 2026

    • Table Oceania Opioid-Induced Constipation Revenue Market Share by Countries from 2016 to 2026

    • Figure Oceania Opioid-Induced Constipation Revenue Market Share by Major Countries in 2020

    • Table Oceania Opioid-Induced Constipation Sales by Countries from 2016 to 2026

    • Table Oceania Opioid-Induced Constipation Sales Market Share by Countries from 2016 to 2026

    • Figure Oceania Opioid-Induced Constipation Sales Market Share by Major Countries in 2020

    • Figure Australia Opioid-Induced Constipation Market Value and Growth Rate from 2016 to 2026

    • Figure Australia Opioid-Induced Constipation Market Volume and Growth Rate from 2016 to 2026

    • Figure New Zealand Opioid-Induced Constipation Market Value and Growth Rate from 2016 to 2026

    • Figure New Zealand Opioid-Induced Constipation Market Volume and Growth Rate from 2016 to 2026

    • Figure Others Opioid-Induced Constipation Market Value and Growth Rate from 2016 to 2026

    • Figure Others Opioid-Induced Constipation Market Volume and Growth Rate from 2016 to 2026

    • Table Oceania Opioid-Induced Constipation Sales by Types from 2016 to 2026

    • Table Oceania Opioid-Induced Constipation Sales Market Share by Types from 2016 to 2026

    • Table Oceania Opioid-Induced Constipation Value by Types from 2016 to 2026

    • Table Oceania Opioid-Induced Constipation Value Market Share by Types from 2016 to 2026

    • Table Oceania Opioid-Induced Constipation Sales by Application from 2016 to 2026

    • Table Oceania Opioid-Induced Constipation Sales Market Share by Application from 2016 to 2026

    • Table Oceania Opioid-Induced Constipation Value by Application from 2016 to 2026

    • Table Oceania Opioid-Induced Constipation Value Market Share by Application from 2016 to 2026

    • Table Production Base and Market Concentration Rate of Raw Material

    • Figure Key Raw Materials Price Trend

    • Figure Manufacturing Process Analysis of Opioid-Induced Constipation

    • Figure Top 10 Market Share in 2020

    • Table Major Downstream Buyers of Opioid-Induced Constipation with Contact Information


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US